ONCOLOGY Vol 36, Issue 9

home / journals / oncology / oncology-vol-36-issue-9
Cancer Pain and Opioid Use Disorder

Cancer Pain and Opioid Use Disorder

Amvrine Ganguly, MD;Marco Michael, MD;Simona Goschin, MD;Kirk Harris, MD;Daniel C. McFarland, DO
September 15th 2022
ArticleReview Article

Investigators support individualized approaches and compassionate care to minimize nonmedical opioid use and opioid use disorder in patients with cancer pain.

Psycho-Oncology and the Relevance of a Biopsychosocial Screening Program

Psycho-Oncology and the Relevance of a Biopsychosocial Screening Program

Cristiane Decat Bergerot, PhD;Paulo Gustavo Bergerot, MD;Lorena Nascimento Manrique Molina, BS;David Lee, BS;Errol J. Philip, PhD;Barry D. Bultz, PhD
September 14th 2022
ArticleClinical Quandaries

Routine biopsychosocial screening of a patient with metastatic renal cell cancer at the Centro de Câncer de Brasília improved symptom management and shrunk costs for both the patient and her caregivers.

Future Directions in the Management of Non–Small Cell Lung Cancer Harboring Driver Mutations

Future Directions in the Management of Non–Small Cell Lung Cancer Harboring Driver Mutations

Roy S. Herbst, MD, PhD
September 14th 2022
ArticlePerspective

Roy S. Herbst, MD, PhD, considers next steps in the management of patients with non–small cell lung cancer harboring genomic drivers.

Mark A. Socinski, MD, on Progression of Lung Cancer Treatment

Mark A. Socinski, MD, on Progression of Lung Cancer Treatment

ONCOLOGY Staff
September 13th 2022
ArticleInterview

“Opportunities to escalate therapies that work well in stage IV into what we consider a more curative setting...are exactly what we need to be looking for.” –Mark A. Socinski, MD

Is Drug Price Negotiation a Concept Whose Time Has Come?

Is Drug Price Negotiation a Concept Whose Time Has Come?

Howard S. Hochster, MD
September 13th 2022
ArticleEditorial

Howard S. Hochster, MD, considers drug price negotiation in this month's Letter to the Readers.